litlas
ログインアカウント作成

Robert H. Jones

1977–2025 年に発表

108
論文数
31,541
被引用数
83
h 指数
104
i10 指数

被引用数

Robert H. Jones の年別被引用数1979 年: 被引用 6 件1980 年: 被引用 12 件1981 年: 被引用 16 件1982 年: 被引用 11 件1983 年: 被引用 25 件1984 年: 被引用 15 件1985 年: 被引用 26 件1986 年: 被引用 19 件1987 年: 被引用 20 件1988 年: 被引用 24 件1989 年: 被引用 15 件1990 年: 被引用 28 件1991 年: 被引用 20 件1992 年: 被引用 17 件1993 年: 被引用 22 件1994 年: 被引用 14 件1995 年: 被引用 38 件1996 年: 被引用 41 件1997 年: 被引用 36 件1998 年: 被引用 42 件1999 年: 被引用 61 件2000 年: 被引用 78 件2001 年: 被引用 107 件2002 年: 被引用 156 件2003 年: 被引用 196 件2004 年: 被引用 211 件2005 年: 被引用 246 件2006 年: 被引用 301 件2007 年: 被引用 265 件2008 年: 被引用 213 件2009 年: 被引用 209 件2010 年: 被引用 212 件2011 年: 被引用 228 件2012 年: 被引用 218 件2013 年: 被引用 172 件2014 年: 被引用 218 件2015 年: 被引用 121 件2016 年: 被引用 117 件2017 年: 被引用 75 件2018 年: 被引用 103 件2019 年: 被引用 379 件2020 年: 被引用 369 件2021 年: 被引用 396 件2022 年: 被引用 302 件2023 年: 被引用 233 件2024 年: 被引用 624 件2025 年: 被引用 417 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,644 件、この内訳の 30.8%イギリス: 引用元論文 683 件、この内訳の 8%中国: 引用元論文 640 件、この内訳の 7.4%カナダ: 引用元論文 432 件、この内訳の 5%ドイツ: 引用元論文 418 件、この内訳の 4.9%イタリア: 引用元論文 383 件、この内訳の 4.5%フランス: 引用元論文 265 件、この内訳の 3.1%オランダ: 引用元論文 263 件、この内訳の 3.1%オーストラリア: 引用元論文 252 件、この内訳の 2.9%スペイン: 引用元論文 182 件、この内訳の 2.1%日本: 引用元論文 177 件、この内訳の 2.1%スウェーデン: 引用元論文 161 件、この内訳の 1.9%
0%30.8%その他 24.2%

機関

分野

  • Medicine79.7%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Health Professions1.6%
  • Immunology and Microbiology1.2%
  • Engineering1.1%
  • Neuroscience1%
  • その他5%

トピック

  • Cardiac Imaging and Diagnostics5.4%
  • Acute Myocardial Infarction Research5.1%
  • Coronary Interventions and Diagnostics4.1%
  • Cardiac and Coronary Surgery Techniques3.7%
  • Cardiac, Anesthesia and Surgical Outcomes2.6%
  • Cardiovascular Function and Risk Factors2.4%
  • その他76.7%

共著者

全論文

検索で開く
  1. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

    著者: Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, Kenneth Chun-Yong Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel Boon Loong Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin Lin, Nathalie Javidi‐Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan Prem Kumar - Molecular Cancer 2023 被引用: 1,908

  2. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy

    著者: Eric J. Velazquez, Kerry L. Lee, Robert H. Jones, Hussein R. Al‐Khalidi, James A. Hill, Julio A. Panza, Robert E. Michler, Robert O. Bonow, Torsten Doenst, Mark C. Petrie, Jae K. Oh, Lilin She, Vanessa Moore, Patrice Desvigne‐Nickens, George Sopko, Jean L. Rouleau - New England Journal of Medicine 2016 被引用: 1,043

  3. Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

    著者: Johann S. de Bono, Nicole Concin, David S. Hong, Fiona Thistlethwaite, Jean-Pascal Machiels, Hendrik‐Tobias Arkenau, Ruth Plummer, Robert H. Jones, Dorte Nielsen, Kristian Windfeld, Srinivas Ghatta, Brian M. Slomovitz, James Spicer, Jeffrey Yachnin, Joo Ern Ang, Paul Morten Mau-Sørensen, Martin Förster, Dearbhaile Catherine Collins, Emma Dean, Reshma Rangwala, Ulrik Lassen - The Lancet Oncology 2019 被引用: 230

  4. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial

    著者: Sacha J. Howell, Angela Casbard, Margherita Carucci, Kate Ingarfield, Rachel Butler, Siân Morgan, Magdalena Meissner, C. Bale, Pavel Bezecny, Sarah Moon, Chris Twelves, Ramachandran Venkitaraman, Simon Waters, Elza C. de Bruin, Gaia Schiavon, Andrew Foxley, Robert H. Jones - The Lancet Oncology 2022 被引用: 143

  5. Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

    著者: Eric J. Velazquez, Kerry L. Lee, Marek Deja, Anil Jain, George Sopko, А. В. Марченко, Imtiaz S. Ali, Gerald Pohost, Siniša Gradinac, William T. Abraham, Michael Yii, Dorairaj Prabhakaran, Hanna Szwed, Paolo Ferrazzi, Mark C. Petrie, Christopher M. O’Connor, Pradit Panchavinnin, Lilin She, Robert O. Bonow, Gena Roush Rankin, Robert H. Jones, Jean‐Lucien Rouleau - New England Journal of Medicine 2011 被引用: 1,293

  6. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

    著者: Robert H. Jones, Angela Casbard, Margherita Carucci, Catrin Cox, Rachel Butler, Fouad Alchami, Tracie‐Ann Madden, C. Bale, Pavel Bezecny, Johnathan Joffe, Sarah Moon, Chris Twelves, Ramachandran Venkitaraman, Simon Waters, Andrew Foxley, Sacha J. Howell - The Lancet Oncology 2020 被引用: 227

  7. Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial

    著者: Noel W. Clarke, Paweł Wiechno, B. Yа. Alekseev, Núria Sala, Robert H. Jones, Ivo Kocák, Vincenzo Emanuele Chiurì, Jacek Jassem, Aude Fléchon, Charles H. Redfern, Carsten Goessl, Joseph E. Burgents, Robert Kozarski, Darren Hodgson, Maria Learoyd, Fred Saad - The Lancet Oncology 2018 被引用: 409

  8. Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery

    著者: Mark F. Newman, Jerry Kirchner, Barbara Phillips‐Bute, Vincent Gaver, Hilary P. Grocott, Robert H. Jones, Daniel B. Mark, J. G. Rêves, James A. Blumenthal - New England Journal of Medicine 2001 被引用: 1,970

  9. Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

    著者: David S. Hong, Nicole Concin, Ignace Vergote, Johann S. de Bono, Brian M. Slomovitz, Yvette Drew, Hendrik‐Tobias Arkenau, Jean-Pascal Machiels, James Spicer, Robert H. Jones, Martin Förster, Nathalie Cornez, Christine Gennigens, Melissa L. Johnson, Fiona Thistlethwaite, Reshma Rangwala, Srinivas Ghatta, Kristian Windfeld, Jeffrey R. Harris, Ulrik Lassen, Robert L. Coleman - Clinical Cancer Research 2019 被引用: 126

  10. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

    著者: Robert O. Bonow, Gerald Maurer, Kerry L. Lee, Thomas A. Holly, Philip F. Binkley, Patrice Desvigne‐Nickens, Jarosław Dróżdż, Pedro Sílvio Farsky, Arthur M. Feldman, Torsten Doenst, Robert E. Michler, Daniel S. Berman, José Carlos Nicolau, Patricia A. Pellikka, Krzysztof Wróbel, Nasri Alotti, Federico M. Asch, Liliana E. Favaloro, Lilin She, Eric J. Velazquez, Robert H. Jones, Julio A. Panza - New England Journal of Medicine 2011 被引用: 879

  11. Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

    著者: Martin Scurr, Tom Pembroke, Anja Bloom, David C. S. Roberts, Amanda Thomson, Kathryn Smart, Hayley Bridgeman, Richard Adams, A. Brewster, Robert H. Jones, Sarah Gwynne, Daniel G. Blount, Richard Harrop, Robert K. Hills, Awen Gallimore, Andrew Godkin - Clinical Cancer Research 2017 被引用: 164

  12. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

    著者: Antonino Glaviano, Seth A. Wander, Richard D. Baird, Kenneth Chun-Yong Yap, Hiu Yan Lam, Masakazu Toi, Daniela Carbone, Birgit Geoerger, Violeta Serra, Robert H. Jones, Joanne Ngeow, Eneda Toska, Justin Stebbing, Karen Crasta, Richard S. Finn, Patrizia Diana, Karla Vuina, Robertus A.M. de Bruin, Uttam Surana, Aditya Bardia, Alan Prem Kumar - Drug Resistance Updates 2024 被引用: 58

  13. A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

    著者: Robert H. Jones, Ruth Plummer, Víctor Moreno, Louise Carter, Desamparados Roda, Elena Garralda, Rebecca Kristeleit, Debashis Sarker, Hendrik‐Tobias Arkenau, Patricia Roxburgh, Harriet S. Walter, Sarah P. Blagden, Alan Anthoney, Barbara Klencke, Mark Kowalski, Udai Banerji - Clinical Cancer Research 2022 被引用: 41

  14. A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer

    著者: Rebecca Kristeleit, Ruth Plummer, Robert H. Jones, Louise Carter, Sarah P. Blagden, Debashis Sarker, Hendrik‐Tobias Arkenau, T.R. Jeffry Evans, Sarah Danson, Stefan N. Symeonides, Gareth J. Veal, Barbara Klencke, Mark Kowalski, Udai Banerji - British Journal of Cancer 2023 被引用: 36

  15. Depression as a risk factor for mortality after coronary artery bypass surgery

    著者: James A. Blumenthal, Heather S. Lett, Michael A. Babyak, William D. White, Peter K. Smith, Daniel B. Mark, Robert H. Jones, Joseph P. Mathew, Mark F. Newman - The Lancet 2003 被引用: 661

  16. Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer.

    著者: Erika Hamilton, Judy S. Wang, Timothy Pluard, Stephen Johnston, Aki Morikawa, Elizabeth Claire Dees, Robert H. Jones, Barbara Haley, Anne Armstrong, Adam L. Cohen, Pamela N. Münster, Gail Lynn Shaw Wright, Fadi Kayali, Manav Korpal, Jianjun Xiao, Jenny Long, Benoit Destenaves, Lei Gao, Antonio Gualberto, Dejan Juric - Journal of Clinical Oncology 2021 被引用: 37

  17. Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring

    著者: Jenny F. Seligmann, David J. Fisher, Louise Brown, Richard Adams, Janet Graham, Philip Quirke, Susan D. Richman, Rachel Butler, Enric Domingo, Andrew Blake, Emma Yates, Michael Braun, Fiona Collinson, Robert H. Jones, Ewan Brown, Emma De Winton, Timothy C. Humphrey, Mahesh Parmar, Richard Kaplan, Richard H. Wilson, Michel Seymour, Tim Maughan - 2021 被引用: 49

  18. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial

    著者: Fred Saad, Antoine Thiery-Vuillemin, Paweł Wiechno, B. Yа. Alekseev, Núria Sala, Robert H. Jones, Ivo Kocák, Vincenzo Emanuele Chiurì, Jacek Jassem, Aude Fléchon, Charles H. Redfern, Jinyu Kang, Joseph E. Burgents, Christopher Gresty, Arnold Degboe, Noel W. Clarke - The Lancet Oncology 2022 被引用: 30

  19. Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer

    著者: Karim Fizazi, Alice Bernard‐Tessier, Guilhem Roubaud, Tapio Utriainen, Philippe Barthélémy, Aude Fléchon, Johannes Van Der Voet, Gwénaëlle Gravis, Raffaele Ratta, Robert H. Jones, Omi Parikh, Minna Tanner, Emmanuel S. Antonarakis, Capucine Baldini, Niamh Peters, Chris Garratt, Tarja Ikonen, Pasi Pohjanjousi, Heikki Joensuu, Natalie Cook - NEJM Evidence 2023 被引用: 24

  20. Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction

    著者: Robert H. Jones, Eric J. Velazquez, Robert E. Michler, George Sopko, Jae K. Oh, Christopher M. O’Connor, James A. Hill, Lorenzo Menicanti, Zygmunt Sadowski, Patrice Desvigne‐Nickens, Jean L. Rouleau, Kerry L. Lee - New England Journal of Medicine 2009 被引用: 724

  21. Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury

    著者: Karla B Neves, Francisco J. Rios, Robert H. Jones, T.R. Jeffry Evans, Augusto C. Montezano, Rhian M. Touyz - Cardiovascular Research 2019 被引用: 45

  22. ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

    著者: Eugene Braunwald, Elliott M. Antman, John W. Beasley, Robert M. Califf, Melvin D. Cheitlin, Judith S. Hochman, Robert H. Jones, Dean J. Kereiakes, Joel Kupersmith, Thomas N. Levin, Carl J. Pepine, John W. Schaeffer, Earl E. Smith, David E. Steward, Pierre Théroux, Raymond J. Gibbons, Joseph S. Alpert, Kim A. Eagle, David P. Faxon, Valentı́n Fuster, Timothy J. Gardner, Gabriel Gregoratos, Richard O. Russell, Sidney C. Smith - Circulation 2000 被引用: 4,515

  23. Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial

    著者: Marek Deja, Paul Grayburn, Benjamin Sun, Vivek Rao, Lilin She, Michał Krejca, Anil Jain, Yeow Leng Chua, Richard C. Daly, Michele Senni, Krzysztof Mokrzycki, Lorenzo Menicanti, Jae K. Oh, Robert E. Michler, Krzysztof Wróbel, André Lamy, Eric J. Velazquez, Kerry L. Lee, Robert H. Jones - Circulation 2012 被引用: 251

  24. Association of Neurocognitive Function and Quality of Life 1 Year After Coronary Artery Bypass Graft (CABG) Surgery

    著者: Barbara Phillips‐Bute, Joseph P. Mathew, James A. Blumenthal, Hilary P. Grocott, Daniel T. Laskowitz, Robert H. Jones, Daniel B. Mark, Mark F. Newman - Psychosomatic Medicine 2006 被引用: 220